Silo Pharma, Inc. (SILO) Q4 2024 Annual Earnings

SILO·Reported March 28, 2025·Before market open

Silo Pharma, Inc. reported Q4 2024 revenue of $18.0K. Diluted EPS came in at $-0.41.

Revenue

$18.0K

Diluted EPS

$-0.41

SEC Filings

Earnings release8-K not filed yet

Annual report10-K · 0001013762-25-004139

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q4 2024 Earnings FAQ

Common questions about Silo Pharma, Inc.'s Q4 2024 earnings report.

Silo Pharma, Inc. (SILO) reported Q4 2024 earnings on March 28, 2025 before market open.

Silo Pharma, Inc. reported revenue of $18.0K and diluted EPS of $-0.41 for Q4 2024.

You can read the 10-K periodic report (0001013762-25-004139) directly on SEC EDGAR. The filing index links above go to sec.gov.